PETITI, JESSICA
 Distribuzione geografica
Continente #
NA - Nord America 716
AS - Asia 460
EU - Europa 359
AF - Africa 42
SA - Sud America 2
OC - Oceania 1
Totale 1.580
Nazione #
US - Stati Uniti d'America 716
SG - Singapore 212
HK - Hong Kong 151
IT - Italia 116
DE - Germania 77
CN - Cina 55
SE - Svezia 55
ZA - Sudafrica 42
JP - Giappone 28
GB - Regno Unito 26
IE - Irlanda 24
RU - Federazione Russa 14
FR - Francia 12
NL - Olanda 11
UA - Ucraina 9
AT - Austria 6
FI - Finlandia 5
IN - India 4
BE - Belgio 2
BR - Brasile 2
IL - Israele 2
IR - Iran 2
TR - Turchia 2
BD - Bangladesh 1
GR - Grecia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 1.580
Città #
Hong Kong 146
Singapore 143
Boardman 97
Ashburn 90
Chandler 83
Nyköping 54
Turin 52
Johannesburg 42
New York 30
Des Moines 29
Tokyo 28
West Jordan 26
Dublin 24
Miami 24
Los Angeles 19
Nuremberg 19
Frankfurt am Main 18
Ogden 11
Moscow 9
Atlanta 6
Guangzhou 6
London 6
Milan 6
Prescot 6
Berlin 5
Las Vegas 5
Chiswick 4
Naples 4
Zhengzhou 4
Beijing 3
Falkenstein 3
Florence 3
Gatchina 3
Lappeenranta 3
Manassas 3
Mumbai 3
Salt Lake City 3
Shenzhen 3
Vienna 3
Azzano San Paolo 2
Bologna 2
Brussels 2
Central 2
Dragoni 2
Forlì 2
Haifa 2
Hanover 2
Helsinki 2
Jiujiang 2
Kilburn 2
New Bedfont 2
Nova Milanese 2
Parma 2
Romainville 2
Rome 2
Roubaix 2
Shijiazhuang 2
Amsterdam 1
Andijan 1
Athens 1
Auckland 1
Bengaluru 1
Buffalo 1
Chelyabinsk 1
Dallas 1
Dhaka 1
Dushanbe 1
Grenoble 1
Gunzenhausen 1
Islington 1
Jiaxing 1
Madeiro 1
Newark 1
Omsk 1
Ravenna 1
Santa Clara 1
Shanghai 1
Stockholm 1
São Paulo 1
Weinan 1
Yiwu 1
Totale 1.086
Nome #
Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia 100
SF3B1 Mutations in Hematological Malignancies 83
Increased Tumour Burden over a 36 Month Period in Chronic Myeloid Leukemia Patients Following Imatinib Discontinuation: Role of Digital PCR 81
Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH 74
MicroRNAs in metabolism for precision treatment of lung cancer 67
Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies 64
Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia 63
Dual-responsive magnetic nanodroplets for controlled oxygen release via ultrasound and magnetic stimulation 62
Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR? 60
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia 56
Standard Operating Procedure to Optimize Resazurin-Based Viability Assays 52
IDH2 mutations PCR Clamping detection kit 52
The total testing process harmonization: the case study of SARS-CoV-2 serological tests 49
Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR 47
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic Cells 46
Development of cellular and humoral response against WT1 protein vaccination in mice 44
Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms 41
Curcumin induces apoptosis in JAK2-mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways 41
Method for the detection of type 1 and 2 mutations of calreticulin (CALR) gene and relative 41
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts 41
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study 40
Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start? 40
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report 39
A novel assay to detect calreticulin mutations in myeloproliferative neoplasms 38
Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes 36
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation 36
Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia 35
Bcl-xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms 34
Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach 34
Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1 33
Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning Techniques 29
Standardized Protocol for Resazurin-Based Viability Assays on A549 Cell Line for Improving Cytotoxicity Data Reliability 29
Treatment-Free Remission in Chronic Myeloid Leukemia Harboring Atypical BCR-ABL1 Transcripts 24
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection 23
Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells 19
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy 19
Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients’ Management 17
Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells 8
Standard Operating Procedure to Optimize Resazurin-Based Viability Assays 8
The influence of fatty acid metabolism on T cell function in lung cancer 3
Totale 1.708
Categoria #
all - tutte 22.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023410 0 0 0 23 47 86 1 41 109 11 83 9
2023/2024613 21 56 49 22 61 65 38 36 122 47 29 67
2024/2025685 31 18 47 15 49 100 94 57 253 21 0 0
Totale 1.708